INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 28 February 2013
|
Total net assets |
£141.8m |
|
NAV per share |
255.6p |
|
Share price |
216.5p |
|
Total value of unquoted investments |
£21.8m |
|
Total number of portfolio companies |
68 |
|
Cash |
(1)% NAV |
|
Cash committed and reserved to unquoted investments |
(5.4)% NAV |
|
Portfolio companies with < 1 year of cash |
15.42% NAV |
Top Ten Holdings
|
Company Name |
% NAV |
|
Celgene Amgen Gilead |
8.4 7.5 6.0 |
|
Onyx |
4.8 |
|
Aptiv |
4.2 |
|
Celldex |
3.6 |
|
Alexion |
3.2 |
|
Insulet |
3.2 |
|
Biogen |
2.9 |
|
Biomarin |
2.8 |
|
|
----------- |
|
Total |
46.6 |
|
Geographical Allocation |
% |
|
United States & Canada |
90 |
|
Europe |
10 |
|
Australia |
1 |
|
Cash |
(1) |
|
|
----------- |
|
Total |
100 |
|
Quoted/Unquoted allocation |
% |
|
Quoted |
86 |
|
Unquoted |
15 |
|
Cash |
(1) |
|
|
----------- |
|
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
21 MARCH 2013